Mutations in the KRAS gene as a predictive biomarker of therapeutic response in patients with colorectal cancer
, , , , , y
22 oct 2021
Acerca de este artículo
Publicado en línea: 22 oct 2021
Páginas: 365 - 375
Recibido: 06 oct 2021
Aceptado: 11 oct 2021
DOI: https://doi.org/10.2478/rrlm-2021-0035
Palabras clave
© 2021 Dragana Jugović et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Jugović, Dragana
Laboratory for Immunology and Genetics, Center for Medical and Clinical biochemistry, University Clinical Center NišSerbia
Nikolić, Marija Vukelić
Faculty of Medicine, Research Center for Biomedicine, University of NišSerbia
Madić, Višnja
Department of Biology and Ecology, Faculty of Science and Mathematics, University of NišSerbia
Branković, Ljiljana
Laboratory for Immunology and Genetics, Center for Medical and Clinical biochemistry, University Clinical Center NišSerbia
Milićević, Radovan
Laboratory for Immunology and Genetics, Center for Medical and Clinical biochemistry, University Clinical Center NišSerbia
Stanojević, Goran
Clinic for digestive surgery, University Clinical Center NišSerbia
Vasiljević, Perica
Department of Biology and Ecology, Faculty of Science and Mathematics, University of NišSerbia